Laura Marandino

Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies

Andrea Necchi, Daniele Raggi, Andrea Gallina et al. · European Urology · 2019 · 313 citations

Urology, Genitourinary Cancer, Muscle-invasive Bladder Carcinoma +7

Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy

Eleonora Ghisoni, Alexandre Wicky, Hasna Bouchaab et al. · European Journal of Cancer · 2021 · 180 citations · Full text

Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer

Andrea Necchi, Daniele Raggi, Andrea Gallina et al. · European Urology · 2020 · 172 citations

Molecular Subtyping, Urology, Genitourinary Cancer +8

Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study

Andrea Necchi, Marco Bandini, Giuseppina Calareso et al. · European Urology · 2019 · 106 citations

Tumor Response, Urology, Oncologic Imaging +7

Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial

Giuseppe Basile, Marco Bandini, Ewan A. Gibb et al. · Clinical Cancer Research · 2022 · 101 citations · Full text